Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

Sebastiaan Somers, MD MSc, Patty Jansen, MD PhD, Hendrik Veelken, MD PhD, Maarten Vermeer, MD PhD, Willem Kraan, MSc, Anne-Roos Schrader, MD, Ward Posthuma, MD PhD, Marcel Nijland, MD, Arjan Diepstra, MD PhD, Marie Jose Kersten, MD PhD, Steven Pals, MD PhD, Arjen Cleven, MD PhD MSc, Joost Vermaat, MD PhD MSc

Blood (2017) 130 (Supplement 1): 4000.

https://doi.org/10.1182/blood.V130.Suppl_1.4000.4000

Published: 2017

Journal Articles

A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Fong Chun Chan, Anja Mottok, Alina S Gerrie, MD, Maryse M Power, MD, Kerry J Savage, MD, Marcel Nijland, MD, Arjan Diepstra, MD PhD, Anke Van den Berg, PhD, Joseph M. Connors, Randy D. Gascoyne, Sohrab P. Shah, David W. Scott, Christian Steidl

Blood (2016) 128 (22): 1093.

https://doi.org/10.1182/blood.V128.22.1093.1093

Published: 2016

Journal Articles

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Joost Kluiver, PhD, Izabella Slezak-Prochazka, PhD, Melanie Winkle, Lydia Visser, PhD, Arjan Diepstra, MD PhD, Bart-Jan Kroesen, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 4820.

https://doi.org/10.1182/blood.V126.23.4820.4820

Published: 2015

Journal Articles

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Fazlyn Reeny Abdul Razak, Arjan Diepstra, MD PhD, Lydia Visser, PhD, Anke Van den Berg, PhD

Blood (2015) 126 (23): 1439.

https://doi.org/10.1182/blood.V126.23.1439.1439

Published: 2015

Journal Articles

Meta-Analysis of Hodgkin Lymphoma and Asthma Genome-Wide Association Scans reveals common variants in GATA3

Blood (2014) 124 (21): 135.

https://doi.org/10.1182/blood.V124.21.135.135

Published: 2014

Journal Articles

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

Yuxuan Liu, Anke Van Den Berg, PhD, Bea Rutgers, Rianne Veenstra, Debora de Jong, Gertrud Kortman, Gustaaf van Imhoff, Lydia Visser, Arjan Diepstra, MD PhD

Blood (2013) 122 (21): 4234.

https://doi.org/10.1182/blood.V122.21.4234.4234

Published: 2013

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

Journal Articles

Long Non-Coding RNAs Are Commonly Deregulated In Hodgkin Lymphoma

Masoumeh Tayari, Klaas Kok, Gertrud Kortman, Jantine Sietzema, Debora de Jong, Martijn Terpstra, Lydia Visser, Arjan Diepstra, MD PhD, Joost Kluiver, Anke van den Berg

Blood (2013) 122 (21): 628.

https://doi.org/10.1182/blood.V122.21.628.628

Published: 2013

Journal Articles

HLA Associated Susceptibility to EBV+ Hodgkin Lymphoma: No Correlation with Infectious Mononucleosis or Number of Circulating EBV+ B Cells.

Arjan Diepstra, MD PhD, Alison M Leese, Annette Pachnio, PhD, Andrew I Bell, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD, Paul AH Moss, MD PhD, Steven P Lee, PhD, Alan B Rickinson, PhD

Blood (2012) 120 (21): 2635.

https://doi.org/10.1182/blood.V120.21.2635.2635

Published: 2012

Journal Articles

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

Zheng Liang, MD, Arjan Diepstra, MD PhD, Chuanhui Xu, MD PhD, Gustaaf W van Imhoff, MD, PhD, Wouter J Plattel, MD, Anke Van Den Berg, PhD, Lydia Visser, PhD

Blood (2012) 120 (21): 2640.

https://doi.org/10.1182/blood.V120.21.2640.2640

Published: 2012

Journal Articles

Strong HLA Class I Expression Is Positively Correlated with the Number of PML Nuclear Bodies and Negatively with the Percentage of SATB1 Positive HRS Cells in EBV+ Classical Hodgkin Lymphoma (cHL)

Yuxuan Liu, Lydia Visser, Rianne Veenstra, Bea Rutgers, Anke Van Den Berg, PhD, Arjan Diepstra, MD PhD

Blood (2012) 120 (21): 3633.

https://doi.org/10.1182/blood.V120.21.3633.3633

Published: 2012

Journal Articles

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

Kushi Kushekhar, Rianne Veenstra, Gabriela Gualco, Pollyanna Domeney, MD, Bouke Hepkema, PhD, Lydia Visser, PhD, Carlos E Bacchi, MD, Arjan Diepstra, MD, PhD, Anke Van Den Berg, PhD

Blood (2011) 118 (21): 4858.

https://doi.org/10.1182/blood.V118.21.4858.4858

Published: 2011

Journal Articles

CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome

Christian Steidl, MD, Arjan Diepstra, MD, PhD, Tang Lee, M.Sc., Pedro Farinha, MD, Adele Telenius, M.Sc., Merrill Boyle, B.Sc., Sohrab P Shah, PhD, Lorena Barclay, Anke Van Den Berg, PhD, Kerry J. Savage, MD MSc, Joseph M. Connors, MD, Randy D. Gascoyne, MD

Blood (2011) 118 (21): 427.

https://doi.org/10.1182/blood.V118.21.427.427

Published: 2011

Journal Articles

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Huang Xin, MD, Arjan Diepstra, MD, PhD, Zifen Gao, MD, PhD, Lydia Visser, PhD, Hans Vos, Wierd Kooistra, Sibrand Poppema, MD, PhD, Bouke Hepkema, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 2688.

https://doi.org/10.1182/blood.V116.21.2688.2688

Published: 2010

Journal Articles

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Wouter Plattel, MD, Anke Van Den Berg, PhD, Anne Marijn Van der Graaf, Hans Vos, Lydia Visser, PhD, Arjan Diepstra, MD, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2010) 116 (21): 748.

https://doi.org/10.1182/blood.V116.21.748.748

Published: 2010

Journal Articles

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Arjan Diepstra, MD, PhD, Xin Huang, Ilja Nolte, PhD, Bouke Hepkema, PhD, Wierd Kooistra, Lydia Visser, PhD, Sibrand Poppema, MD, PhD, Anke Van Den Berg, PhD

Blood (2010) 116 (21): 749.

https://doi.org/10.1182/blood.V116.21.749.749

Published: 2010

Journal Articles

Serum TARC Levels Correspond with Tumor Load and Response to Chemotherapy in Classical Hodgkin Lymphoma Patients.

Arjan Diepstra, MD, PhD, Anne Marijn van der Graaf, Hans JTWM Vos, Lydia Visser, PhD, Anke Van Den Berg, PhD, Gustaaf van Imhoff, MD, PhD

Blood (2009) 114 (22): 3663.

https://doi.org/10.1182/blood.V114.22.3663.3663

Published: 2009

Journal Articles

Haplotype-Based Sequencing To Delineate the Associated HLA Class I Region for EBV Positive Hodgkin Lymphoma.

Marijke Niens, MSc, Anke van den Berg, PhD, Arjan Diepstra, MD, Ilja M. Nolte, PhD, Gerrit van der Steege, PhD, Ruth F. Jarrett, MD, Siebrand Poppema, MD, Gerard J. te Meerman, PhD

Blood (2005) 106 (11): 971.

https://doi.org/10.1182/blood.V106.11.971.971

Published: 2005

Journal Articles

Polymorphisms and Lack of or Aberrant Expression of HLA Class I and II May Influence Antigen Presentation in Classical Hodgkin Lymphoma.

Arjan Diepstra, MD, Sibrand Poppema, MD, PhD, Gerard te Meerman, PhD, Marijke Niens, MSc, Ilja Nolte, MSc, PhD, Edo Vellenga, MD, PhD, Gustaaf van Imhoff, MD, Joost Kluiver, MSc, Anke van den Berg, MSc, PhD

Blood (2005) 106 (11): 20.

https://doi.org/10.1182/blood.V106.11.20.20

Published: 2005

Journal Articles

Population Based Genotyping of Human Leukocyte Antigen (HLA) in Hodgkin Lymphoma: EBV Positive HL Is Associated with HLA Class I and EBV Negative HL Is Associated with HLA Class III.

Arjan Diepstra, MD, Marijke Niens, MSc, Edo Vellenga, MD, PhD, Gerard J. te Meerman, PhD, Michael Schaapveld, PhD, Ilja M. Nolte, PhD, Gustaaf W. van Imhoff, MD, Sibrand Poppema, MD, PhD

Blood (2004) 104 (11): 432.

https://doi.org/10.1182/blood.V104.11.432.432

Published: 2004

NARROW

High Prevalence of Oncogenic MYD88 and CD79B Mutations in Intravascular Large B-Cell Lymphoma: Implication for Therapy with Bruton's Kinase Inhibitors?

A Novel Prognostic Model Based on Tumor Microenvironment Biology in Relapse Biopsies Predicts Post-Autologous Stem Cell Transplantation Outcomes in Classical Hodgkin Lymphoma

Mir-155 Enhances B-Cell Lymphoma Growth By Targeting TBRG1

Mutations in CD58 and Other Immune System Related Genes in Hodgkin Lymphoma

Meta-Analysis of Hodgkin Lymphoma and Asthma Genome-Wide Association Scans reveals common variants in GATA3

Specific PML Isoforms and SATB1 Affect HLA Expression In Classical Hodgkin Lymphoma

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Long Non-Coding RNAs Are Commonly Deregulated In Hodgkin Lymphoma

HLA Associated Susceptibility to EBV+ Hodgkin Lymphoma: No Correlation with Infectious Mononucleosis or Number of Circulating EBV+ B Cells.

Expression, Prognostic Value and Function of IGF1R in Hodgkin Lymphoma.

Strong HLA Class I Expression Is Positively Correlated with the Number of PML Nuclear Bodies and Negatively with the Percentage of SATB1 Positive HRS Cells in EBV+ Classical Hodgkin Lymphoma (cHL)

EBV and HLA Associations In Classical Hodgkin Lymphoma Patients From Brazil

CSF1R Expression of Hodgkin Reed Sternberg Cells Is Associated with the Number of Macrophages in the Tumor Microenvironment and Is Correlated with Treatment Outcome

HLA Class I and EBV Positive Classical Hodgkin Lymphoma In the Chinese Population

Mid-Treatment Plasma Levels of Thymus Activated and Regulated Chemokine (TARC) Predict Treatment Outcome In Classical Hodgkin Lymphoma Patients

Protective and Predisposing HLA Alleles In Dutch Classical Hodgkin Lymphoma Patients

Serum TARC Levels Correspond with Tumor Load and Response to Chemotherapy in Classical Hodgkin Lymphoma Patients.

Haplotype-Based Sequencing To Delineate the Associated HLA Class I Region for EBV Positive Hodgkin Lymphoma.

Polymorphisms and Lack of or Aberrant Expression of HLA Class I and II May Influence Antigen Presentation in Classical Hodgkin Lymphoma.

Population Based Genotyping of Human Leukocyte Antigen (HLA) in Hodgkin Lymphoma: EBV Positive HL Is Associated with HLA Class I and EBV Negative HL Is Associated with HLA Class III.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only